Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Apr;76(1):61–67.

Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.

P Engel 1, J Inglés 1, O de la Calle 1, T Gallart 1
PMCID: PMC1541746  PMID: 2500274

Abstract

Individual leukaemic B cells of chronic lymphocytic leukaemia (CLL) do not proliferate to B cell growth factor (BCGF) or interleukin 2 (IL-2) when co-stimulated with immunoglobulin (Ig) ligands. To exclude possible defective signalling via surface Ig (sIg), phorbol myristate acetate (PMA) plus calcium ionophore (A23187) were used to activate purified CLL B cells and compared with staphylococcal protein A coupled to sepharose beads (Seph-PA). RNA synthesis and phenotypic changes after PMA plus A23187 stimulation indicate that CLL B cells from (10) different individuals are similarly able to undergo the G0 to the G1 phase transition and express surface activation antigens. In contrast, they are variable in the capacity to show DNA synthesis, which occurred in only six out of 10 cases. Even in the presence of BCGF (10%, v/v) or IL-2 (50 U/ml) four out of nine CLL B cells activated with PMA plus A23187 or PMA alone were still unable to proliferate although they were induced to express CD23, 4F2, CD25 and OKT9 antigens by PMA plus A23187. However, PMA plus A23187 induced IgM secretion which increased further in response to IL-2 even in the absence of DNA synthesis. Moreover, in other CLL B cell populations, the unresponsiveness to growth factors upon co-stimulation with Ig ligands (Seph-PA) may simply reflect a defective signalling via sIg cross-linking which can be circumvented by PMA plus A23187 stimulation. Recombinant Interferon-gamma (50 U/ml) failed to affect DNA synthesis and IgM secretion.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aman P., Gordon J., Klein G. TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes. Immunology. 1984 Jan;51(1):27–34. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun;63(6):1424–1433. [PubMed] [Google Scholar]
  3. Caligaris-Cappio F., Bergui L., Tesio L., Corbascio G., Tousco F., Marchisio P. C. Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia. Blood. 1986 Jan;67(1):233–239. [PubMed] [Google Scholar]
  4. Catovsky D., Pittman S., O'Brien M., Cherchi M., Costello C., Foa R., Pearce E., Hoffbrand A. V., Janossy G., Ganeshaguru K. Multiparameter studies in lymphoid leukemias. Am J Clin Pathol. 1979 Oct;72(4 Suppl):736–745. [PubMed] [Google Scholar]
  5. Clevers H. C., Versteegen J. M., Logtenberg T., Gmelig-Meyling F. H., Ballieux R. E. Synergistic action of A23187 and phorbol ester on human B cell activation. J Immunol. 1985 Dec;135(6):3827–3830. [PubMed] [Google Scholar]
  6. Cohen H. J. Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes. J Clin Invest. 1975 Jan;55(1):84–93. doi: 10.1172/JCI107921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Forsgren A., Svedjelund A., Wigzell H. Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol. 1976 Mar;6(3):207–213. doi: 10.1002/eji.1830060312. [DOI] [PubMed] [Google Scholar]
  8. Gallart T., Bladé J., Martínez-Quesada J., Sierra J., Rozman C., Vives J. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD. Immunology. 1985 May;55(1):45–57. [PMC free article] [PubMed] [Google Scholar]
  9. Guy G. R., Bunce C. M., Gordon J., Michell R. H., Brown G. A combination of calcium ionophore and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulates the growth of purified resting B cells. Scand J Immunol. 1985 Nov;22(5):591–596. doi: 10.1111/j.1365-3083.1985.tb01919.x. [DOI] [PubMed] [Google Scholar]
  10. Hivroz C., Grillot-Courvalin C., Brouet J. C., Seligmann M. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Eur J Immunol. 1986 Aug;16(8):1001–1004. doi: 10.1002/eji.1830160821. [DOI] [PubMed] [Google Scholar]
  11. Kabelitz D., Pfeffer K., von Steldern D., Bartmann P., Brudler O., Nerl C., Wagner H. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells. J Immunol. 1985 Oct;135(4):2876–2881. [PubMed] [Google Scholar]
  12. Karray S., Vazquez A., Merle-Beral H., Olive D., Debre P., Galanaud P. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes. J Immunol. 1987 Jun 1;138(11):3824–3828. [PubMed] [Google Scholar]
  13. Kehrl J. H., Muraguchi A., Fauci A. S. Differential expression of cell activation markers after stimulation of resting human B lymphocytes. J Immunol. 1984 Jun;132(6):2857–2861. [PubMed] [Google Scholar]
  14. Larsson L. G., Gray H. E., Tötterman T., Pettersson U., Nilsson K. Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A. 1987 Jan;84(1):223–227. doi: 10.1073/pnas.84.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nakagawa T., Nakagawa N., Goldstein H., Volkman D. J., Fauci A. S. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation. J Immunol. 1986 Nov 15;137(10):3175–3182. [PubMed] [Google Scholar]
  16. Roifman C. M., Benedict S. H., Cheung R. K., Gelfand E. W. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin. Eur J Immunol. 1987 May;17(5):701–706. doi: 10.1002/eji.1830170519. [DOI] [PubMed] [Google Scholar]
  17. Tamaki T., Yonezawa T., Kanakura Y., Katagiri S., Mizutani H., Kitani T., Tarui S. Mitogenic response of neoplastic B cells: comparison of reactivity to Staphylococcus aureus Cowan I and anti-immunoglobulin antibodies. Clin Exp Immunol. 1986 Apr;64(1):181–187. [PMC free article] [PubMed] [Google Scholar]
  18. Tanaka T., Saiki O., Doi S., Hatakeyama M., Doi T., Kono T., Mori H., Fujii M., Sugamura K., Negoro S. Functional interleukin 2 receptors on B cells lacking Tac antigens. Eur J Immunol. 1987 Sep;17(9):1379–1382. doi: 10.1002/eji.1830170925. [DOI] [PubMed] [Google Scholar]
  19. Thorley-Lawson D. A., Nadler L. M., Bhan A. K., Schooley R. T. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol. 1985 May;134(5):3007–3012. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES